Skip to main content
. 2022 Oct 3;3:100131. doi: 10.1016/j.crphar.2022.100131

Table 3.

A tabular representation of the miRNA expressions seen in the numerous distinct subtypes of breast cancer cells.

Sl. No. miRNAs Sample type Expression Targeted gene Oncogenic or TSG role Reference
1 miRNA-127-3p, miRNA-148b, miRNA-376a, miRNA-376c, miRNA-409-3p, miRNA-652, and miRNA-801 Plasma Higher expression ITGA6 Oncogene Hironaka-Mitsuhashi et al. (2022)
2 miRNA-1, miRNA-92a, miRNA-133a, and miRNA-133b Serum Over or higher expression SERTAD3 Oncogene Hironaka-Mitsuhashi et al. (2022)
3 miRNA-195 Tissue Down-regulation SEMA6D Oncogene Baxter et al. (2021)
4 miRNA-92 Tissue Less expression ERβ1 Oncogene Smith et al. (2015).
5 miRNA −26b Tissue Down-regulation TNKS1BP1, CPSF7, COL12A1 Oncogene Verghese et al. (2013)
6 miRNA −222 Tissue Up-regulation LBR Oncogene Chatterjee et al. (2019)
7 miRNA-155 Tissue High-expression tumor
protein 53-induced nuclear protein 1
Oncogene Zhang et al. (2013)
8 miRNA-124-3p Tissue Lower expression MGAT5 TSG Yan et al. (2019)
9 miRNA-205 Tissue Over-expression TG2 TSG Seo et al. (2019)
10 miRNA -21-3p Tissue Dysregulation CYP1A1 TSG Lo et al. (2017)
11 miRNA-628 Tissue Over-expression SOS1 TSG Lin et al. (2018)
12 miRNA-382-3p and miRNA-1246 Serum Up-regulated CCNG2 Oncogene Fu et al. (2016)
13 miRNA-598-3p and miRNA-184 Serum Down-regulated LRP6 Oncogene Fu et al. (2016)
14 miRNA-24-3p Plasma Higher expression p27Kip1 Oncogene Jang et al. (2021)
15 miRNA-206 Tissue Up-regulated Neurokinin-1
Receptor
Oncogene Zhou et al. (2019)